41 related articles for article (PubMed ID: 34773446)
1. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
Zhang L; Fan M; Wang S; Xu M; Li L
J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
[TBL] [Abstract][Full Text] [Related]
2. Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes.
Zhang L; Fan M; Li L
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37983902
[No Abstract] [Full Text] [Related]
3. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
4. Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer.
Zhang L; Fan M; Li L
J Imaging Inform Med; 2024 Feb; 37(1):13-24. PubMed ID: 38343210
[TBL] [Abstract][Full Text] [Related]
5. Generative adversarial network-based synthesis of contrast-enhanced MR images from precontrast images for predicting histological characteristics in breast cancer.
Fan M; Cao X; Lü F; Xie S; Yu Z; Chen Y; Lü Z; Li L
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537294
[No Abstract] [Full Text] [Related]
6. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
7. MRI-based machine learning models predict the malignant biological behavior of meningioma.
Li M; Liu L; Qi J; Qiao Y; Zeng H; Jiang W; Zhu R; Chen F; Huang H; Wu S
BMC Med Imaging; 2023 Sep; 23(1):141. PubMed ID: 37759192
[TBL] [Abstract][Full Text] [Related]
8. A weakly supervised NMF method to decipher molecular subtype-related dynamic patterns in breast DCE-MR images.
Guan J; Fan M; Li L
Phys Med Biol; 2023 Oct; 68(21):. PubMed ID: 37757849
[No Abstract] [Full Text] [Related]
9. Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.
Ji Y; Whitney HM; Li H; Liu P; Giger ML; Zhang X
Radiology; 2023 Apr; 307(1):e220984. PubMed ID: 36594836
[TBL] [Abstract][Full Text] [Related]
10. Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.
Whitney HM; Drukker K; Edwards A; Papaioannou J; Medved M; Karczmar G; Giger ML
Magn Reson Imaging; 2021 Oct; 82():111-121. PubMed ID: 34174331
[TBL] [Abstract][Full Text] [Related]
11. MRI-Based Kinetic Heterogeneity Evaluation in the Accurate Access of Axillary Lymph Node Status in Breast Cancer Using a Hybrid CNN-RNN Model.
Guo YJ; Yin R; Zhang Q; Han JQ; Dou ZX; Wang PB; Lu H; Liu PF; Chen JJ; Ma WJ
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38205712
[TBL] [Abstract][Full Text] [Related]
12. Radiomic Signatures Based on Mammography and Magnetic Resonance Imaging as New Markers for Estimation of Ki-67 and HER-2 Status in Breast Cancer.
Fan Y; Zhao D; Su J; Yuan W; Niu S; Guo W; Jiang W
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):890-897. PubMed ID: 37948363
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI subregion radiomics for preoperative assessment of high-risk subregions in microsatellite instability of rectal cancer patients: A multicenter study.
Cai Z; Xu Z; Chen Y; Zhang R; Guo B; Chen H; Ouyang F; Chen X; Chen X; Liu D; Luo C; Li X; Liu W; Zhou C; Guan X; Liu Z; Zhao H; Hu Q
Int J Surg; 2024 Mar; ():. PubMed ID: 38498392
[TBL] [Abstract][Full Text] [Related]
14. Predicting hormone receptors and PAM50 subtypes of breast cancer from multi-scale lesion images of DCE-MRI with transfer learning technique.
Ming W; Li F; Zhu Y; Bai Y; Gu W; Liu Y; Sun X; Liu X; Liu H
Comput Biol Med; 2022 Nov; 150():106147. PubMed ID: 36201887
[TBL] [Abstract][Full Text] [Related]
15. The value of the malignant subregion-based texture analysis in predicting the Ki-67 status in breast cancer.
Hua C; Wenwen C; Huijuan R; Ting P; Jin Z
Front Oncol; 2024; 14():1359925. PubMed ID: 38835373
[TBL] [Abstract][Full Text] [Related]
16. Molecular-subtype guided automatic invasive breast cancer grading using dynamic contrast-enhanced MRI.
Sun R; Wei L; Hou X; Chen Y; Han B; Xie Y; Nie S
Comput Methods Programs Biomed; 2023 Dec; 242():107804. PubMed ID: 37716219
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors.
Chen L; Choyke PL; Chan TH; Chi CY; Wang G; Wang Y
IEEE Trans Med Imaging; 2011 Dec; 30(12):2044-58. PubMed ID: 21708498
[TBL] [Abstract][Full Text] [Related]
18. Joint Optimization of k-t Sampling Pattern and Reconstruction of DCE MRI for Pharmacokinetic Parameter Estimation.
Zou J; Cao Y
IEEE Trans Med Imaging; 2022 Nov; 41(11):3320-3331. PubMed ID: 35714093
[TBL] [Abstract][Full Text] [Related]
19. A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma.
Chen L; Yin G; Wang Z; Liu Z; Sui C; Chen K; Song T; Xu W; Qi L; Li X
Biosci Trends; 2024 Jun; ():. PubMed ID: 38853000
[TBL] [Abstract][Full Text] [Related]
20. Early Identification of Pathologic Complete Response to Neoadjuvant Chemotherapy Using Multiphase DCE-MRI by Siamese Network in Breast Cancer: A Longitudinal Multicenter Study.
Huang Y; Cao Y; Hu X; Lan X; Chen H; Tang S; Li L; Cheng Y; Gong X; Wang W; Jiang F; Yin T; Wang X; Zhang J
J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38109316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
